Metrics as of 10/17/2026, 08:51 AM (Berlin time), refresh in progress.
Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers…
1D
-3.3%
1W
+0.4%
1M
+1.6%
6M
-12.5%
YTD
-22.3%
1Y
+53.3%
2Y
+56.6%
5Y
-36.6%
10Y
+23.1%
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~142% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$35.00
CONSENSUS
US$35.00
MEDIAN
US$35.00
PRICE TARGET HIGH
US$35.00
0
STRONG BUY
8
BUY
1
HOLD
2
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 12/10/2026
P/E
20.66
P/B
2.28
EV/EBITDA
10.3
RETURN ON EQUITY
3.5%
NET MARGIN
9.1%
DEBT/EQUITY
0.06
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
96.7%
FLOAT SHARES
21,895,102
AVG. DAILY VOLUME (30D)
253,552
Dodd Sheri Louise
Birkemeyer Elaine M.
Volkart Carmen B
Pearson Andrea
Huggenberger Raymond
Tactile Systems Technology, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Sheri Louise Dodd, the company employs around 1,086 people.
The IPO was on 28/07/2016; the stock trades on NASDAQ under the ticker TCMD.
11 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$35.00, ranging from US$35.00 to US$35.00, with a median of US$35.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly 142% stronger than usual.
No, Tactile Systems Technology currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Tactile Systems Technology against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.